Showing results (261-270 of 560) with videos related to

Sort By:
Pageof 56
Cancer Cell|July 10, 2019
Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal CancerAndrew Woolston, Khurum Khan, Georgia Spain, et al.
Diseases of the Colon and Rectum|September 10, 2011
Timing of surgery following preoperative therapy in rectal cancer: the need for a prospective randomized trial?Jessica Evans, Diana Tait, Ian Swift, et al.
The European Journal of General Practice|September 5, 2015
Good practice statements on safe laboratory testing: A mixed methods study by the LINNEAUS collaboration on patient safety in primary carePaul Bowie, Eleanor Forrest, Julie Price, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 25, 2012
The importance of audit to monitor applications of procedures and improve primary angioplasty resultsPeter F Ludman, Mark A de Belder, James M McLenachan, et al.
Hematology (Amsterdam, Netherlands)|April 25, 2007
Gemcitabine, cisplatin and methylprednisolone (GEM-P) with or without Rituximab in relapsed and refractory patients with diffuse large B cell lymphoma (DLBCL)Bhawna Sirohi, David Cunningham, Andy Norman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 15, 2023
The Real-World Evidence Workstream in EUreccA 2025: How the Task Was AddressedLinda A Murphy, Ron Akehurst, Oriol Solà-Morales, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|October 1, 2013
"Chronic" metastatic pancreatic acinar cell carcinomaFerdinando C M Cananzi, Akali Jayanth, Bruno Lorenzi, et al.
Clinical Colorectal Cancer|December 21, 2013
Correlation of lactate dehydrogenase isoenzyme profile with outcome in patients with advanced colorectal cancer treated with chemotherapy and bevacizumab or cediranib: Retrospective analysis of the HORIZON I studyJair Bar, Stuart Spencer, Shethah Morgan, et al.
Clinical Medicine (London, England)|March 12, 2013
Discordance between cancer prevalence and training: a need for an increase in oncology educationSarah Payne, Danny Burke, Janine Mansi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 27, 2023
Structure and Content of a Taxonomy to Support the Use of Real-World Evidence by Health Technology Assessment Practitioners and Healthcare Decision MakersLinda A Murphy, Ron Akehurst, Oriol Solà-Morales, et al.
Pageof 56